ATE201046T1 - Polypeptide und dafür kodierende dns, die mit humanen malariaparasiten assoziiert sind - Google Patents

Polypeptide und dafür kodierende dns, die mit humanen malariaparasiten assoziiert sind

Info

Publication number
ATE201046T1
ATE201046T1 AT91903249T AT91903249T ATE201046T1 AT E201046 T1 ATE201046 T1 AT E201046T1 AT 91903249 T AT91903249 T AT 91903249T AT 91903249 T AT91903249 T AT 91903249T AT E201046 T1 ATE201046 T1 AT E201046T1
Authority
AT
Austria
Prior art keywords
dna coding
proteins
malaria parasite
polypeptides
human malaria
Prior art date
Application number
AT91903249T
Other languages
English (en)
Inventor
Kathryn Jane Hallowes Robson
Original Assignee
Imp College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imp College Innovations Ltd filed Critical Imp College Innovations Ltd
Application granted granted Critical
Publication of ATE201046T1 publication Critical patent/ATE201046T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
AT91903249T 1990-02-05 1991-02-04 Polypeptide und dafür kodierende dns, die mit humanen malariaparasiten assoziiert sind ATE201046T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909002512A GB9002512D0 (en) 1990-02-05 1990-02-05 Polypeptides and dna encoding same
PCT/GB1991/000162 WO1991011516A1 (en) 1990-02-05 1991-02-04 Polypeptides and dna encoding same, associated with human malaria parasites

Publications (1)

Publication Number Publication Date
ATE201046T1 true ATE201046T1 (de) 2001-05-15

Family

ID=10670433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91903249T ATE201046T1 (de) 1990-02-05 1991-02-04 Polypeptide und dafür kodierende dns, die mit humanen malariaparasiten assoziiert sind

Country Status (10)

Country Link
EP (1) EP0514411B1 (de)
JP (1) JP3067206B2 (de)
AT (1) ATE201046T1 (de)
AU (1) AU643506B2 (de)
DE (1) DE69132599T2 (de)
DK (1) DK0514411T3 (de)
ES (1) ES2157196T3 (de)
GB (1) GB9002512D0 (de)
GR (1) GR3036312T3 (de)
WO (1) WO1991011516A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0513421D0 (en) 2005-06-30 2005-08-03 Glaxosmithkline Biolog Sa Vaccines
AP2010005166A0 (en) 2007-08-13 2010-02-28 Glaxosmithkline Biolog Sa Vaccines
US9580482B2 (en) 2012-02-17 2017-02-28 Children's Medical Center Corporation Conformation-stabilized TRAP antigens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
GB8706599D0 (en) * 1987-03-19 1987-04-23 Hoffmann La Roche Plasmodium falciparum merozoite antigen peptides
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same

Also Published As

Publication number Publication date
DE69132599T2 (de) 2002-05-29
JPH05503937A (ja) 1993-06-24
WO1991011516A1 (en) 1991-08-08
GR3036312T3 (en) 2001-10-31
DE69132599D1 (de) 2001-06-13
GB9002512D0 (en) 1990-04-04
EP0514411A1 (de) 1992-11-25
ES2157196T3 (es) 2001-08-16
EP0514411B1 (de) 2001-05-09
AU643506B2 (en) 1993-11-18
JP3067206B2 (ja) 2000-07-17
AU7231591A (en) 1991-08-21
DK0514411T3 (da) 2001-05-28

Similar Documents

Publication Publication Date Title
FI104255B1 (fi) Menetelmä ihmisen seerumialbumiinin N-terminaalifragmentteja sisältävien fuusioproteiinien valmistamiseksi
DK0700445T3 (da) Stressproteiner og anvendelser deraf
DE69232871D1 (de) Polypeptide des hepatitis c-virus (hiv)
DE3473298D1 (en) Method of producing and selectively isolating proteins and polypeptides, recombinant and expression vector therefor and fusion protein able to bind to the constant region of immunoglobulins
NZ219113A (en) Hiv peptide containing epitope of the env protein
NO872988D0 (no) Pattedyr-interleukin-4.
IL83236A0 (en) Preparation of functional human urokinase proteins
DK0604418T3 (da) Isolerede viralproteincytokinantagonister
CA2093659A1 (en) Dna sequence encoding bovine .alpha.-lactalbumin and methods of use
IL70776A (en) Recombinant dna molecule encoding at least one polypeptide displaying the immunogenicity of at least one merozoite antigen or asexual blood stage antigen of p.falciparum,vectors comprising the dna molecule,host cells transformed thereby,immunogenic polypeptides produced by host cells and compositions containing the polypeptides
ATE201046T1 (de) Polypeptide und dafür kodierende dns, die mit humanen malariaparasiten assoziiert sind
DK218886D0 (da) Tvaerreaktive og beskyttende epitoper af circumsporozoit-proteiner
GB2176191A (en) Antigens of plasmodium falciparum
NZ220500A (en) Recombinant felv polypeptide; vaccine and expression vectors
AU1216988A (en) Immunogenic fusion proteins which contain Epstein-Barr virus protein
PT85220A (en) Dna sequence recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides obtained products and preparations containing same
IL91609A0 (en) Allelic variants of plasmodium falciparum merozoite surface antigen
EP0392820A3 (de) Plasmodium circumsporozoite Proteinanaloge ohne repetierte Sequenzen
FI870501A0 (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
DK0388738T3 (da) Plasmodium merozoit rhoptries-antigen og derivater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee